chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Mental disorder, Pain of skin, Pemphigoid, Pruritus, Skin injury
Clinical narrative: Received Pfizer COVID-19 Vaccine and developed an for first-time a diagnosed skin auto-immune disease called Bullous Pemphigoid. This has damaged my skin with painful and itchy skin blister on my entire face, body, and extremities. This is negatively impacting my mental health. I received the Pfizer COVID-19 Vaccine from Hospital. I never had this skin issue and it started shortly after receiving Pfizer COVID-19 vaccine. Dermatologist performed Biopsy of Skin Blisters which confirmed the diagnosis of Bullous Pemphigoid. I have been taking months of oral prednisone & mycophenolate & topical clobetasol ointment to suppress the Bullous Pemphigoid. I am now immunocompromised and recently been experiencing falls and difficulty walking. I was hospitalized 2 weeks ago at Hospital and currently in a skills nursing facility receiving rehabilitation services.
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain, Loss of personal independence in daily activities
Clinical narrative: After receiving the Pfizer Covid 2nd shot. After two weeks my injection site has serious pain and is having an effect on normal operation.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity
Clinical narrative: Headache; chills; some fatigue; This is a spontaneous report from a contactable consumer (patient) reported for herself that a 73-years-old female patient received second dose of BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, batch/lot number: EL3247), via an unknown route of administration in right arm on an unknown date (at the age of 73-years-old) at 04:15 (24 hours clock) as single for COVID-19 immunisation at hospital. The patient's medical history and concomitant medications were not reported. The patient received first dose of BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, Batch/ lot number: EK9231), via an unknown route of administration on an unknown date as historical vaccine as single for COVID-19 immunisation and experienced little bit of soreness in my arm. On an unknown date, 18 hours later of second dose, the patient experienced headache, chills and some fatigue. Any issues (side effects, complaints, etc.) were not reporting with a Pfizer product. No event required a visit to emergency room or physician office. No treatment received. The outcome of the event some fatigue was recovered on an unknown date, while the outcome of the remaining events was unknown.  Follow-up attempts completed. No further information expected.
Age: 73.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Headache
Clinical narrative: Headache; chills; some fatigue; This is a spontaneous report from a contactable consumer (patient) reported for herself that a 73-years-old female patient received second dose of BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, batch/lot number: EL3247), via an unknown route of administration in right arm on an unknown date (at the age of 73-years-old) at 04:15 (24 hours clock) as single for COVID-19 immunisation at hospital. The patient's medical history and concomitant medications were not reported. The patient received first dose of BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, Batch/ lot number: EK9231), via an unknown route of administration on an unknown date as historical vaccine as single for COVID-19 immunisation and experienced little bit of soreness in my arm. On an unknown date, 18 hours later of second dose, the patient experienced headache, chills and some fatigue. Any issues (side effects, complaints, etc.) were not reporting with a Pfizer product. No event required a visit to emergency room or physician office. No treatment received. The outcome of the event some fatigue was recovered on an unknown date, while the outcome of the remaining events was unknown.  Follow-up attempts completed. No further information expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Muscle spasms
Clinical narrative: muscle sores; This is a spontaneous report from a contactable consumer or other non hcp. This 59-year-old-female consumer reported in response to Non HCP letter sent in a cross reference case. This is one of the 2 reports. A 59-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EJ1685; Expiration Date: Mar2021), dose 1 via an unspecified route of administration, administered in Arm Left on 19Dec2020 (59-years-old) as dose 1, single for covid-19 immunization.  Medical history included crohn's disease from Mar2010. Patient was on no medication. The patient's concomitant medications were not reported.  The patient experienced muscle sores on 19Dec2020. Vaccination Facility Type was a Hospital. The patient had muscles sore a few days. Time of Onset was 6 hours. The patient had received the 2nd dose on 09Jan2021. The events did not cause Emergency Room or Physician Office visit. Prior Vaccinations (within 4 weeks) was none. No Antipyretic was used for the pain.  Outcome of the event was unknown.  Follow-up (19May2021): Follow-up attempts completed. No further information expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Myalgia
Clinical narrative: muscle sores; This is a spontaneous report from a contactable consumer or other non hcp. This 59-year-old-female consumer reported in response to Non HCP letter sent in a cross reference case. This is one of the 2 reports. A 59-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EJ1685; Expiration Date: Mar2021), dose 1 via an unspecified route of administration, administered in Arm Left on 19Dec2020 (59-years-old) as dose 1, single for covid-19 immunization.  Medical history included crohn's disease from Mar2010. Patient was on no medication. The patient's concomitant medications were not reported.  The patient experienced muscle sores on 19Dec2020. Vaccination Facility Type was a Hospital. The patient had muscles sore a few days. Time of Onset was 6 hours. The patient had received the 2nd dose on 09Jan2021. The events did not cause Emergency Room or Physician Office visit. Prior Vaccinations (within 4 weeks) was none. No Antipyretic was used for the pain.  Outcome of the event was unknown.  Follow-up (19May2021): Follow-up attempts completed. No further information expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain
Clinical narrative: muscle sores; This is a spontaneous report from a contactable consumer or other non hcp. This 59-year-old-female consumer reported in response to Non HCP letter sent in a cross reference case. This is one of the 2 reports. A 59-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EJ1685; Expiration Date: Mar2021), dose 1 via an unspecified route of administration, administered in Arm Left on 19Dec2020 (59-years-old) as dose 1, single for covid-19 immunization.  Medical history included crohn's disease from Mar2010. Patient was on no medication. The patient's concomitant medications were not reported.  The patient experienced muscle sores on 19Dec2020. Vaccination Facility Type was a Hospital. The patient had muscles sore a few days. Time of Onset was 6 hours. The patient had received the 2nd dose on 09Jan2021. The events did not cause Emergency Room or Physician Office visit. Prior Vaccinations (within 4 weeks) was none. No Antipyretic was used for the pain.  Outcome of the event was unknown.  Follow-up (19May2021): Follow-up attempts completed. No further information expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Contusion, Gait disturbance, Mobility decreased, Pain in extremity
Clinical narrative: A large hard bump at my injection site.; Extreme pain when lifting my arm to stretch, wash my back or buckle my seatbelt. Arm aches from top of left shoulder to the elbow.; unable to sleep on left side; progressive weakness in left hand; bruise on inner left thigh; This is a spontaneous report from a contactable nurse, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EJ1686) via intramuscular route of administration in the arm left on an unknown date in Jan2021 at 13:00 (at the age of 60-year-old) as a single dose for COVID-19immunisation. Medical history included hypothyroidism. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and acetylsalicylic acid (ASA); for unknown indication from an unknown date. The patient had no known allergies to food, medications and other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL1284) via intramuscular route of administration in the arm left on an unknown date in Dec2021 at 13:00 (at the age of 60-year-old) as a single dose for COVID-19immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Jan2021 the patient experienced a large hard bump at her injection site, extreme pain when lifting her arm to stretch, wash her back or buckle her seatbelt, unable to sleep on left side, arm aches from top of left shoulder to the elbow. Progressive weakness in left hand, bruise on inner left thigh. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of AE and included ultrasound and blood test on an unknown date. The clinical outcome of the event large hard bump at injection site, extreme pain when lifting her arm to stretch, wash her back or buckle her seatbelt,  unable to sleep on left side, arm aches from top of left shoulder to the elbow, progressive weakness in left hand and bruise on inner left thigh was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Sleep disorder, Thrombosis, Vaccine positive rechallenge
Clinical narrative: A large hard bump at my injection site.; Extreme pain when lifting my arm to stretch, wash my back or buckle my seatbelt. Arm aches from top of left shoulder to the elbow.; unable to sleep on left side; progressive weakness in left hand; bruise on inner left thigh; This is a spontaneous report from a contactable nurse, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EJ1686) via intramuscular route of administration in the arm left on an unknown date in Jan2021 at 13:00 (at the age of 60-year-old) as a single dose for COVID-19immunisation. Medical history included hypothyroidism. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and acetylsalicylic acid (ASA); for unknown indication from an unknown date. The patient had no known allergies to food, medications and other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL1284) via intramuscular route of administration in the arm left on an unknown date in Dec2021 at 13:00 (at the age of 60-year-old) as a single dose for COVID-19immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Jan2021 the patient experienced a large hard bump at her injection site, extreme pain when lifting her arm to stretch, wash her back or buckle her seatbelt, unable to sleep on left side, arm aches from top of left shoulder to the elbow. Progressive weakness in left hand, bruise on inner left thigh. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of AE and included ultrasound and blood test on an unknown date. The clinical outcome of the event large hard bump at injection site, extreme pain when lifting her arm to stretch, wash her back or buckle her seatbelt,  unable to sleep on left side, arm aches from top of left shoulder to the elbow, progressive weakness in left hand and bruise on inner left thigh was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test, Contusion, Injection site induration, Injection site mass, Mobility decreased
Clinical narrative: A large hard bump at my injection site.; Extreme pain when lifting my arm to stretch, wash my back or buckle my seatbelt. Arm aches from top of left shoulder to the elbow.; unable to sleep on left side; progressive weakness in left hand; bruise on inner left thigh; This is a spontaneous report from a contactable nurse, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EJ1686) via intramuscular route of administration in the arm left on an unknown date in Jan2021 at 13:00 (at the age of 60-year-old) as a single dose for COVID-19immunisation. Medical history included hypothyroidism. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and acetylsalicylic acid (ASA); for unknown indication from an unknown date. The patient had no known allergies to food, medications and other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL1284) via intramuscular route of administration in the arm left on an unknown date in Dec2021 at 13:00 (at the age of 60-year-old) as a single dose for COVID-19immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Jan2021 the patient experienced a large hard bump at her injection site, extreme pain when lifting her arm to stretch, wash her back or buckle her seatbelt, unable to sleep on left side, arm aches from top of left shoulder to the elbow. Progressive weakness in left hand, bruise on inner left thigh. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of AE and included ultrasound and blood test on an unknown date. The clinical outcome of the event large hard bump at injection site, extreme pain when lifting her arm to stretch, wash her back or buckle her seatbelt,  unable to sleep on left side, arm aches from top of left shoulder to the elbow, progressive weakness in left hand and bruise on inner left thigh was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Muscular weakness, Pain, Pain in extremity, Sleep disorder, Ultrasound scan
Clinical narrative: A large hard bump at my injection site.; Extreme pain when lifting my arm to stretch, wash my back or buckle my seatbelt. Arm aches from top of left shoulder to the elbow.; unable to sleep on left side; progressive weakness in left hand; bruise on inner left thigh; This is a spontaneous report from a contactable nurse, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EJ1686) via intramuscular route of administration in the arm left on an unknown date in Jan2021 at 13:00 (at the age of 60-year-old) as a single dose for COVID-19immunisation. Medical history included hypothyroidism. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and acetylsalicylic acid (ASA); for unknown indication from an unknown date. The patient had no known allergies to food, medications and other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL1284) via intramuscular route of administration in the arm left on an unknown date in Dec2021 at 13:00 (at the age of 60-year-old) as a single dose for COVID-19immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Jan2021 the patient experienced a large hard bump at her injection site, extreme pain when lifting her arm to stretch, wash her back or buckle her seatbelt, unable to sleep on left side, arm aches from top of left shoulder to the elbow. Progressive weakness in left hand, bruise on inner left thigh. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of AE and included ultrasound and blood test on an unknown date. The clinical outcome of the event large hard bump at injection site, extreme pain when lifting her arm to stretch, wash her back or buckle her seatbelt,  unable to sleep on left side, arm aches from top of left shoulder to the elbow, progressive weakness in left hand and bruise on inner left thigh was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Contusion, Muscular weakness, Pain in extremity, Sleep disorder, Vaccination site swelling
Clinical narrative: A large hard bump at my injection site.; Extreme pain when lifting my arm to stretch, wash my back or buckle my seatbelt. Arm aches from top of left shoulder to the elbow.; unable to sleep on left side; progressive weakness in left hand; bruise on inner left thigh; This is a spontaneous report from a contactable nurse, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EJ1686) via intramuscular route of administration in the arm left on an unknown date in Jan2021 at 13:00 (at the age of 60-year-old) as a single dose for COVID-19immunisation. Medical history included hypothyroidism. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and acetylsalicylic acid (ASA); for unknown indication from an unknown date. The patient had no known allergies to food, medications and other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL1284) via intramuscular route of administration in the arm left on an unknown date in Dec2021 at 13:00 (at the age of 60-year-old) as a single dose for COVID-19immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Jan2021 the patient experienced a large hard bump at her injection site, extreme pain when lifting her arm to stretch, wash her back or buckle her seatbelt, unable to sleep on left side, arm aches from top of left shoulder to the elbow. Progressive weakness in left hand, bruise on inner left thigh. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of AE and included ultrasound and blood test on an unknown date. The clinical outcome of the event large hard bump at injection site, extreme pain when lifting her arm to stretch, wash her back or buckle her seatbelt,  unable to sleep on left side, arm aches from top of left shoulder to the elbow, progressive weakness in left hand and bruise on inner left thigh was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Ear discomfort, Fatigue, Headache, Injection site pain
Clinical narrative: dizziness; nausea; extreme migraine like headaches; numbness in my thighs; heightened sense of taste and smell for 5 days; heightened sense of taste and smell for 5 days; full body fatigue; This is a spontaneous report from a contactable consumer or other non hcp. A 42-years-old non pregnancy female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EN5318) via an unspecified route of administration in Arm Left on 26Jan2021 08:45 (age at vaccination 42years old, Pregnant at Time of Vaccination: No) as single dose for covid-19 immunisation. Medical history included asthma from an unknown date and unknown if ongoing, drug hypersensitivity from an unknown date and unknown if ongoing, dust allergy from an unknown date and unknown if ongoing, food allergy from an unknown date and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. She did not receive other medications in two weeks. There were no concomitant medications. Since the vaccination, the patient had not been tested positive for COVID-19. On 27Jan2021 06:00 the patient experienced dizziness, nausea, extreme migraine like headaches, numbness in my thighs, heightened sense of taste and smell for 5 days, heightened sense of taste and smell for 5 days, full body fatigue. Clinical course was reported as I have reported twice, but 1000-word count is not enough for my detailed note taking. So I am filing a 3rd time, and will be more general about my side effects: I had moderate waves of dizziness, nausea, extreme migraine like head-aches, or pressure in my head (or what sounded like migraines to my doctor), pressure in my head, numbness in my thighs, heightened sense of taste and smell for 5 days (non-distorted) intense pressure on the bridge of my nose, full body fatigue-these side effects did not peak or lessen until about day 8 or nine. The symptoms are milder, but I still experience all of them in waves (except for heightened smell and taste) on a daily basis-someday the fatigue seems ok, but other days after 10 hours of sleep I re-experience a day long extreme body fatigue. The patient did not receive any treatment for the adverse events. The clinical outcome of the event was not recovered.  No follow-up attempts possible. No further information expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Nausea, Paranasal sinus discomfort, Parosmia, Pyrexia, Taste disorder
Clinical narrative: dizziness; nausea; extreme migraine like headaches; numbness in my thighs; heightened sense of taste and smell for 5 days; heightened sense of taste and smell for 5 days; full body fatigue; This is a spontaneous report from a contactable consumer or other non hcp. A 42-years-old non pregnancy female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EN5318) via an unspecified route of administration in Arm Left on 26Jan2021 08:45 (age at vaccination 42years old, Pregnant at Time of Vaccination: No) as single dose for covid-19 immunisation. Medical history included asthma from an unknown date and unknown if ongoing, drug hypersensitivity from an unknown date and unknown if ongoing, dust allergy from an unknown date and unknown if ongoing, food allergy from an unknown date and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. She did not receive other medications in two weeks. There were no concomitant medications. Since the vaccination, the patient had not been tested positive for COVID-19. On 27Jan2021 06:00 the patient experienced dizziness, nausea, extreme migraine like headaches, numbness in my thighs, heightened sense of taste and smell for 5 days, heightened sense of taste and smell for 5 days, full body fatigue. Clinical course was reported as I have reported twice, but 1000-word count is not enough for my detailed note taking. So I am filing a 3rd time, and will be more general about my side effects: I had moderate waves of dizziness, nausea, extreme migraine like head-aches, or pressure in my head (or what sounded like migraines to my doctor), pressure in my head, numbness in my thighs, heightened sense of taste and smell for 5 days (non-distorted) intense pressure on the bridge of my nose, full body fatigue-these side effects did not peak or lessen until about day 8 or nine. The symptoms are milder, but I still experience all of them in waves (except for heightened smell and taste) on a daily basis-someday the fatigue seems ok, but other days after 10 hours of sleep I re-experience a day long extreme body fatigue. The patient did not receive any treatment for the adverse events. The clinical outcome of the event was not recovered.  No follow-up attempts possible. No further information expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Upper-airway cough syndrome
Clinical narrative: dizziness; nausea; extreme migraine like headaches; numbness in my thighs; heightened sense of taste and smell for 5 days; heightened sense of taste and smell for 5 days; full body fatigue; This is a spontaneous report from a contactable consumer or other non hcp. A 42-years-old non pregnancy female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EN5318) via an unspecified route of administration in Arm Left on 26Jan2021 08:45 (age at vaccination 42years old, Pregnant at Time of Vaccination: No) as single dose for covid-19 immunisation. Medical history included asthma from an unknown date and unknown if ongoing, drug hypersensitivity from an unknown date and unknown if ongoing, dust allergy from an unknown date and unknown if ongoing, food allergy from an unknown date and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. She did not receive other medications in two weeks. There were no concomitant medications. Since the vaccination, the patient had not been tested positive for COVID-19. On 27Jan2021 06:00 the patient experienced dizziness, nausea, extreme migraine like headaches, numbness in my thighs, heightened sense of taste and smell for 5 days, heightened sense of taste and smell for 5 days, full body fatigue. Clinical course was reported as I have reported twice, but 1000-word count is not enough for my detailed note taking. So I am filing a 3rd time, and will be more general about my side effects: I had moderate waves of dizziness, nausea, extreme migraine like head-aches, or pressure in my head (or what sounded like migraines to my doctor), pressure in my head, numbness in my thighs, heightened sense of taste and smell for 5 days (non-distorted) intense pressure on the bridge of my nose, full body fatigue-these side effects did not peak or lessen until about day 8 or nine. The symptoms are milder, but I still experience all of them in waves (except for heightened smell and taste) on a daily basis-someday the fatigue seems ok, but other days after 10 hours of sleep I re-experience a day long extreme body fatigue. The patient did not receive any treatment for the adverse events. The clinical outcome of the event was not recovered.  No follow-up attempts possible. No further information expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Fatigue, Hypoaesthesia, Migraine, Nausea
Clinical narrative: dizziness; nausea; extreme migraine like headaches; numbness in my thighs; heightened sense of taste and smell for 5 days; heightened sense of taste and smell for 5 days; full body fatigue; This is a spontaneous report from a contactable consumer or other non hcp. A 42-years-old non pregnancy female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EN5318) via an unspecified route of administration in Arm Left on 26Jan2021 08:45 (age at vaccination 42years old, Pregnant at Time of Vaccination: No) as single dose for covid-19 immunisation. Medical history included asthma from an unknown date and unknown if ongoing, drug hypersensitivity from an unknown date and unknown if ongoing, dust allergy from an unknown date and unknown if ongoing, food allergy from an unknown date and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. She did not receive other medications in two weeks. There were no concomitant medications. Since the vaccination, the patient had not been tested positive for COVID-19. On 27Jan2021 06:00 the patient experienced dizziness, nausea, extreme migraine like headaches, numbness in my thighs, heightened sense of taste and smell for 5 days, heightened sense of taste and smell for 5 days, full body fatigue. Clinical course was reported as I have reported twice, but 1000-word count is not enough for my detailed note taking. So I am filing a 3rd time, and will be more general about my side effects: I had moderate waves of dizziness, nausea, extreme migraine like head-aches, or pressure in my head (or what sounded like migraines to my doctor), pressure in my head, numbness in my thighs, heightened sense of taste and smell for 5 days (non-distorted) intense pressure on the bridge of my nose, full body fatigue-these side effects did not peak or lessen until about day 8 or nine. The symptoms are milder, but I still experience all of them in waves (except for heightened smell and taste) on a daily basis-someday the fatigue seems ok, but other days after 10 hours of sleep I re-experience a day long extreme body fatigue. The patient did not receive any treatment for the adverse events. The clinical outcome of the event was not recovered.  No follow-up attempts possible. No further information expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Parosmia, Taste disorder
Clinical narrative: dizziness; nausea; extreme migraine like headaches; numbness in my thighs; heightened sense of taste and smell for 5 days; heightened sense of taste and smell for 5 days; full body fatigue; This is a spontaneous report from a contactable consumer or other non hcp. A 42-years-old non pregnancy female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EN5318) via an unspecified route of administration in Arm Left on 26Jan2021 08:45 (age at vaccination 42years old, Pregnant at Time of Vaccination: No) as single dose for covid-19 immunisation. Medical history included asthma from an unknown date and unknown if ongoing, drug hypersensitivity from an unknown date and unknown if ongoing, dust allergy from an unknown date and unknown if ongoing, food allergy from an unknown date and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. She did not receive other medications in two weeks. There were no concomitant medications. Since the vaccination, the patient had not been tested positive for COVID-19. On 27Jan2021 06:00 the patient experienced dizziness, nausea, extreme migraine like headaches, numbness in my thighs, heightened sense of taste and smell for 5 days, heightened sense of taste and smell for 5 days, full body fatigue. Clinical course was reported as I have reported twice, but 1000-word count is not enough for my detailed note taking. So I am filing a 3rd time, and will be more general about my side effects: I had moderate waves of dizziness, nausea, extreme migraine like head-aches, or pressure in my head (or what sounded like migraines to my doctor), pressure in my head, numbness in my thighs, heightened sense of taste and smell for 5 days (non-distorted) intense pressure on the bridge of my nose, full body fatigue-these side effects did not peak or lessen until about day 8 or nine. The symptoms are milder, but I still experience all of them in waves (except for heightened smell and taste) on a daily basis-someday the fatigue seems ok, but other days after 10 hours of sleep I re-experience a day long extreme body fatigue. The patient did not receive any treatment for the adverse events. The clinical outcome of the event was not recovered.  No follow-up attempts possible. No further information expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Bone pain, Dizziness, Fatigue, Headache, Nausea
Clinical narrative: dizziness; nausea; extreme migraine like headaches; numbness in my thighs; heightened sense of taste and smell for 5 days; heightened sense of taste and smell for 5 days; full body fatigue; This is a spontaneous report from a contactable consumer or other non hcp. A 42-years-old non pregnancy female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EN5318) via an unspecified route of administration in Arm Left on 26Jan2021 08:45 (age at vaccination 42years old, Pregnant at Time of Vaccination: No) as single dose for covid-19 immunisation. Medical history included asthma from an unknown date and unknown if ongoing, drug hypersensitivity from an unknown date and unknown if ongoing, dust allergy from an unknown date and unknown if ongoing, food allergy from an unknown date and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. She did not receive other medications in two weeks. There were no concomitant medications. Since the vaccination, the patient had not been tested positive for COVID-19. On 27Jan2021 06:00 the patient experienced dizziness, nausea, extreme migraine like headaches, numbness in my thighs, heightened sense of taste and smell for 5 days, heightened sense of taste and smell for 5 days, full body fatigue. Clinical course was reported as I have reported twice, but 1000-word count is not enough for my detailed note taking. So I am filing a 3rd time, and will be more general about my side effects: I had moderate waves of dizziness, nausea, extreme migraine like head-aches, or pressure in my head (or what sounded like migraines to my doctor), pressure in my head, numbness in my thighs, heightened sense of taste and smell for 5 days (non-distorted) intense pressure on the bridge of my nose, full body fatigue-these side effects did not peak or lessen until about day 8 or nine. The symptoms are milder, but I still experience all of them in waves (except for heightened smell and taste) on a daily basis-someday the fatigue seems ok, but other days after 10 hours of sleep I re-experience a day long extreme body fatigue. The patient did not receive any treatment for the adverse events. The clinical outcome of the event was not recovered.  No follow-up attempts possible. No further information expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pain in extremity, Paranasal sinus discomfort, Parosmia, Rhinorrhoea, Taste disorder
Clinical narrative: dizziness; nausea; extreme migraine like headaches; numbness in my thighs; heightened sense of taste and smell for 5 days; heightened sense of taste and smell for 5 days; full body fatigue; This is a spontaneous report from a contactable consumer or other non hcp. A 42-years-old non pregnancy female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EN5318) via an unspecified route of administration in Arm Left on 26Jan2021 08:45 (age at vaccination 42years old, Pregnant at Time of Vaccination: No) as single dose for covid-19 immunisation. Medical history included asthma from an unknown date and unknown if ongoing, drug hypersensitivity from an unknown date and unknown if ongoing, dust allergy from an unknown date and unknown if ongoing, food allergy from an unknown date and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. She did not receive other medications in two weeks. There were no concomitant medications. Since the vaccination, the patient had not been tested positive for COVID-19. On 27Jan2021 06:00 the patient experienced dizziness, nausea, extreme migraine like headaches, numbness in my thighs, heightened sense of taste and smell for 5 days, heightened sense of taste and smell for 5 days, full body fatigue. Clinical course was reported as I have reported twice, but 1000-word count is not enough for my detailed note taking. So I am filing a 3rd time, and will be more general about my side effects: I had moderate waves of dizziness, nausea, extreme migraine like head-aches, or pressure in my head (or what sounded like migraines to my doctor), pressure in my head, numbness in my thighs, heightened sense of taste and smell for 5 days (non-distorted) intense pressure on the bridge of my nose, full body fatigue-these side effects did not peak or lessen until about day 8 or nine. The symptoms are milder, but I still experience all of them in waves (except for heightened smell and taste) on a daily basis-someday the fatigue seems ok, but other days after 10 hours of sleep I re-experience a day long extreme body fatigue. The patient did not receive any treatment for the adverse events. The clinical outcome of the event was not recovered.  No follow-up attempts possible. No further information expected.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Vaccination site pain
Clinical narrative: dizziness; nausea; extreme migraine like headaches; numbness in my thighs; heightened sense of taste and smell for 5 days; heightened sense of taste and smell for 5 days; full body fatigue; This is a spontaneous report from a contactable consumer or other non hcp. A 42-years-old non pregnancy female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: EN5318) via an unspecified route of administration in Arm Left on 26Jan2021 08:45 (age at vaccination 42years old, Pregnant at Time of Vaccination: No) as single dose for covid-19 immunisation. Medical history included asthma from an unknown date and unknown if ongoing, drug hypersensitivity from an unknown date and unknown if ongoing, dust allergy from an unknown date and unknown if ongoing, food allergy from an unknown date and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. She did not receive other medications in two weeks. There were no concomitant medications. Since the vaccination, the patient had not been tested positive for COVID-19. On 27Jan2021 06:00 the patient experienced dizziness, nausea, extreme migraine like headaches, numbness in my thighs, heightened sense of taste and smell for 5 days, heightened sense of taste and smell for 5 days, full body fatigue. Clinical course was reported as I have reported twice, but 1000-word count is not enough for my detailed note taking. So I am filing a 3rd time, and will be more general about my side effects: I had moderate waves of dizziness, nausea, extreme migraine like head-aches, or pressure in my head (or what sounded like migraines to my doctor), pressure in my head, numbness in my thighs, heightened sense of taste and smell for 5 days (non-distorted) intense pressure on the bridge of my nose, full body fatigue-these side effects did not peak or lessen until about day 8 or nine. The symptoms are milder, but I still experience all of them in waves (except for heightened smell and taste) on a daily basis-someday the fatigue seems ok, but other days after 10 hours of sleep I re-experience a day long extreme body fatigue. The patient did not receive any treatment for the adverse events. The clinical outcome of the event was not recovered.  No follow-up attempts possible. No further information expected.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Eye pain, Head discomfort, Headache, Tinnitus
Clinical narrative: ocular migraine; ringing in her ear; pressure in the head; tachycardia; dizziness that turned to vertigo and she still has vertigo till this day; dizziness that turned to vertigo and she still has vertigo till this day; This is a spontaneous report from a contactable consumer (patient) via a 41-Year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and expiry date was not provided) dose 1 via an unspecified route of administration on 22Jan2021 at 10:20 dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. That night (on 22Jan2021), she had an ocular migraine for 7 days straight, ringing in her ear, pressure in the head, tachycardia that lasted 2 weeks, dizziness that turned to vertigo and she still has vertigo till this day, and she was now seeing a neurologist and taking medications. She was also seeing a vestibular specialist. She has not received her 2nd dose. The patient wanted to know whether ringing of the ear after the covid vaccine part of the severe allergic reactions was noted in the fact sheet. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dizziness, Head discomfort, Ophthalmic migraine, Tachycardia, Tinnitus
Clinical narrative: ocular migraine; ringing in her ear; pressure in the head; tachycardia; dizziness that turned to vertigo and she still has vertigo till this day; dizziness that turned to vertigo and she still has vertigo till this day; This is a spontaneous report from a contactable consumer (patient) via a 41-Year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and expiry date was not provided) dose 1 via an unspecified route of administration on 22Jan2021 at 10:20 dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. That night (on 22Jan2021), she had an ocular migraine for 7 days straight, ringing in her ear, pressure in the head, tachycardia that lasted 2 weeks, dizziness that turned to vertigo and she still has vertigo till this day, and she was now seeing a neurologist and taking medications. She was also seeing a vestibular specialist. She has not received her 2nd dose. The patient wanted to know whether ringing of the ear after the covid vaccine part of the severe allergic reactions was noted in the fact sheet. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Vertigo
Clinical narrative: ocular migraine; ringing in her ear; pressure in the head; tachycardia; dizziness that turned to vertigo and she still has vertigo till this day; dizziness that turned to vertigo and she still has vertigo till this day; This is a spontaneous report from a contactable consumer (patient) via a 41-Year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and expiry date was not provided) dose 1 via an unspecified route of administration on 22Jan2021 at 10:20 dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. That night (on 22Jan2021), she had an ocular migraine for 7 days straight, ringing in her ear, pressure in the head, tachycardia that lasted 2 weeks, dizziness that turned to vertigo and she still has vertigo till this day, and she was now seeing a neurologist and taking medications. She was also seeing a vestibular specialist. She has not received her 2nd dose. The patient wanted to know whether ringing of the ear after the covid vaccine part of the severe allergic reactions was noted in the fact sheet. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, Balance disorder, Dizziness, Head discomfort, Headache
Clinical narrative: ocular migraine; ringing in her ear; pressure in the head; tachycardia; dizziness that turned to vertigo and she still has vertigo till this day; dizziness that turned to vertigo and she still has vertigo till this day; This is a spontaneous report from a contactable consumer (patient) via a 41-Year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and expiry date was not provided) dose 1 via an unspecified route of administration on 22Jan2021 at 10:20 dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. That night (on 22Jan2021), she had an ocular migraine for 7 days straight, ringing in her ear, pressure in the head, tachycardia that lasted 2 weeks, dizziness that turned to vertigo and she still has vertigo till this day, and she was now seeing a neurologist and taking medications. She was also seeing a vestibular specialist. She has not received her 2nd dose. The patient wanted to know whether ringing of the ear after the covid vaccine part of the severe allergic reactions was noted in the fact sheet. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Magnetic resonance imaging, Migraine, Tinnitus, Tremor, Vestibular function test
Clinical narrative: ocular migraine; ringing in her ear; pressure in the head; tachycardia; dizziness that turned to vertigo and she still has vertigo till this day; dizziness that turned to vertigo and she still has vertigo till this day; This is a spontaneous report from a contactable consumer (patient) via a 41-Year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and expiry date was not provided) dose 1 via an unspecified route of administration on 22Jan2021 at 10:20 dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. That night (on 22Jan2021), she had an ocular migraine for 7 days straight, ringing in her ear, pressure in the head, tachycardia that lasted 2 weeks, dizziness that turned to vertigo and she still has vertigo till this day, and she was now seeing a neurologist and taking medications. She was also seeing a vestibular specialist. She has not received her 2nd dose. The patient wanted to know whether ringing of the ear after the covid vaccine part of the severe allergic reactions was noted in the fact sheet. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.